BWX TECHNOLOGIES, INC.

BWXT

CIK 0001486957 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$886M
↑+18.7% +$140Mvs FY2024 (Q4)
Operating Income
$92M
↓-0.2% -$206Kvs FY2024 (Q4)
Net Income
$74M
↑+4.6% +$3Mvs FY2024 (Q4)
Gross Profit
$0
↓-100.0% -$37Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
51/100
  • Profitability
    37ROIC 12.5% (10% = solid, 20%+ = moat)
  • Liquidity
    91Current Ratio 2.32 (above 1.5 = solid)
  • Leverage
    18D/E 1.64 (under 0.5 = conservative)
  • Efficiency
    54Asset Turnover 0.90x (1.0+ = capital-efficient)
  • Growth
    79Revenue YoY +18.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    27Op Margin 10.4% · trend -1.4pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project BWXT's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 85.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$107.23
Total enterprise IV
$9.85B
Diluted shares
0.09B
Terminal PV
$7.65B (78% of total)
Year-5 FCF
$901M
YearProjected FCFDiscounted PV
+1$369M$336M
+2$461M$381M
+3$577M$433M
+4$721M$492M
+5$901M$560M
Terminal$12.32B$7.65B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$185M
investment in PP&E
Dividends paid (TTM)
$92M
cash returned to holders
Stock buybacks (TTM)
$30M
share count reduction
Stock-based comp (TTM)
$26M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$4.27B
everything owned
Total liabilities
$3.04B
everything owed
Stockholders' equity
$1.23B
shareholder claim
Net debt
$1.52B
LT debt minus cash

Recent performance · 64 quarters

Revenue↑+18.7% +$140M
$886M
Net Income↑+30.9% +$22M
$93M
Free Cash Flow↓-74.7% -$168M
$57M
Operating Margin↓-2.0pts
10.4%

Drill down